John Burn
Burn, John, MD, MRCP
VIAF ID: 55834957 (Personal)
Permalink: http://viaf.org/viaf/55834957
Preferred Forms
- 100 1 _ ‡a Burn, John, ‡c MD, MRCP
-
- 100 0 _ ‡a John Burn
4xx's: Alternate Name Forms (4)
Works
Title | Sources |
---|---|
The Gemini inheritance [VR] c1990: | |
Harveian Oration and dinner : prediction and prevention in the genomic era, 2019: | |
Linkage analysis in adenomatous polyposis coli: the use of four closely linked DNA probes in 20 UK families | |
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial | |
Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy | |
Lynch syndrome: history, causes, diagnosis, treatment and prevention (CAPP2 trial). | |
Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic | |
The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome | |
Maternal serum screening for Down's syndrome: a survey of midwives' views | |
May spina bifida result from an X-linked defect in a selective abortion mechanism? | |
Meckel syndrome: what are the minimum diagnostic criteria? | |
Medical directory, 1992: | |
Methylenetetrahydrofolate reductase and neural tube defects | |
MLH1 Differential Allelic Expression in Mutation Carriers and Controls | |
An MLH1 haplotype is over-represented on chromosomes carrying an HNPCC predisposing mutation in MLH1 | |
Molecular characterization of the spectrum of genomic deletions in the mismatch repair genesMSH2,MLH1,MSH6, andPMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC) | |
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome | |
Monozygotic twins with chromosome 22q11 deletion and discordant phenotype | |
Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality | |
Mutation detection in exons 1-14 of the adenomatous polyposis coli gene: identification of an alternatively spliced transcript. | |
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease | |
Mutation (variation) databases and registries: a rationale for coordination of efforts | |
Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth | |
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus | |
Neural tube defects as an X-linked condition | |
Neuroferritinopathy: a window on the role of iron in neurodegeneration. | |
Neuroferritinopathy in a French family with late onset dominant dystonia | |
Neuropathological and biochemical investigation of Hereditary Ferritinopathycases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress | |
New dysmorphic syndrome with choanal atresia in siblings | |
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in and : A Prospective Lynch Syndrome Database Study | |
The North Cumbria Community Genetics Project | |
A novel FTL insertion causing neuroferritinopathy | |
A novel panel of short mononucleotide repeats linked to informative polymorphisms enabling effective high volume low cost discrimination between mismatch repair deficient and proficient tumours | |
Peutz-Jeghers syndrome: a systematic review and recommendations for management | |
Planning the human variome project: the Spain report. | |
Point of care testing for improving risk- benefit ratio of aspirin and warfarin | |
Polymorphisms of the DNA repair gene XRCC1 and the frequency of somatic mutations at the glycophorin A locus in newborns | |
The poor patient with diabetes ‘should live like a saint’ | |
Population based, prospective study of the care of women with epilepsy in pregnancy | |
Population frequencies of three DNA alleles linked to the Duchenne muscular dystrophy gene. | |
Population screening in cystic fibrosis | |
PPM-X: a new X-linked mental retardation syndrome with psychosis, pyramidal signs, and macroorchidism maps to Xq28 | |
Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients. | |
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. | |
Prevalence, phenotype and architecture of developmental disorders caused by de novo mutation | |
Primidone teratogenicity or noonan syndrome? | |
Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis | |
The protocol for a european double-blind trial of aspirin and resistant starch in familial adenomatous polyposis: The capp study | |
RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies | |
A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. | |
RE: Correspondence from Wieczorek & Gillessen-Kaesbach and Hing & Parisi | |
Recognition of clinical genetics in Europe | |
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe. | |
Recurrence risks in offspring of adults with major heart defects: results from first cohort of British collaborative study. | |
Refinement of the NHS locus on chromosome Xp22.13 and analysis of five candidate genes | |
Relevance of the Human Genome Project to inherited metabolic disease | |
Reply to Burn and Sheth | |
Reply to Howlett and Mortimer | |
The role of aspirin in preventing colorectal cancer | |
Scoliosis in association with infantile hypophosphatasia: a case study in two siblings | |
A sensitive and scalable microsatellite instability assay to diagnose constitutional mismatch repair deficiency by sequencing of peripheral blood leukocytes | |
Sequencing-based microsatellite instability testing using as few as six markers for high-throughput clinical diagnostics | |
Should we sequence everyone's genome? Yes. | |
Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype | |
Smith-Lemli-Opitz syndromes: Do they include the Pallister-Hall syndrome? | |
Spectrum of movement disorders in neuroferritinopathy | |
Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlh1 mutations. | |
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism | |
Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom | |
Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects | |
Transition from cylindroma to spiradenoma in CYLD-defective tumours is associated with reduced DKK2 expression | |
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trial | |
Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction | |
UFD1L is not the monogenic basis for heart defects associated with the CATCH phenotype | |
The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations | |
The "unnatural" history of colorectal cancer in Lynch syndrome: lessons from colonoscopy surveillance | |
An unusual gait following the discovery of a new disease | |
Uptake of hysterectomy and bilateral salpingo-oophorectomy in carriers of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report | |
Urgent improvements needed to diagnose and manage Lynch syndrome. | |
Williams syndrome | |
Xp21 DNA PROBE IN DIAGNOSIS OF MUSCULAR DYSTROPHY AND SPINAL MUSCULAR ATROPHY | |
চিঠিপত্র |